Chart of the Week: Gilead Sciences
Hey everyone. Happy Wednesday. It’s time for our chart of the week. And we’re gonna focus in on biotech pharmaceutical name Gilead; GILD is the symbol. Let’s take a look at this chart. It’s been looking pretty bullish lately.
As you can see from the lows back in early May, the stock has been making some higher highs and higher lows. That is our textbook definition of an uptrend.
You can see we’ve connected three or four tops, three or four bottoms, and made a nice upward channel from the beginning of May to now. So for about six months we’ve seen this stock driving within a range of about $95 to the low side and to the high side at about $126. So a 30-point range for a $125 stock is pretty wide. It’s got some volatility in there. And you can see it in the chart.
Recently, the stock pulled back down to the lower end at the end of October to about $114 and made a really nice bold move, along with some of these other names in the pharmaceuticals like Merck and Pfizer and Bristol Meyers and the like.
I like Gilead over here. It had a big spike up and rejected last week the $128 level. It’s kind of consolidating within that range right now.
The last couple of days when the stock market has been down, Gilead has been up. That’s good relative strength, and you can see that good relative strength on the top of the chart over here with making higher lows and higher highs as well.
MACD just crossed over for a buy signal. You can see that down over here.
We’ve had good volume on the stock over the past 3 1/2 months, since September. And I think buyers are still coming into the stock. I think we got a good chance to get to $140 on this thing before the end of the year, possibly into early 2026.
So take a look at Gilead; GILD. Thanks so much for watching everyone.
Don’t miss a single one of Bob’s charts! Get the Chart of the Week in your inbox every week!
